BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 16608370)

  • 41. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognosis and management of scleroderma and scleroderma-like disorders in children.
    Black CM
    Clin Exp Rheumatol; 1994; 12 Suppl 10():S75-81. PubMed ID: 7955633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consensus-based recommendations for the management of juvenile systemic sclerosis.
    Foeldvari I; Culpo R; Sperotto F; Anton J; Avcin T; Baildam E; Boros C; Chaitow J; Constantin T; Kasapcopur O; Knupp Feitosa de Oliveira S; Pilkington C; Toplak N; van Royen A; Saad Magalhaes C; Vastert SJ; Wulffraat N; Zulian F
    Rheumatology (Oxford); 2021 Apr; 60(4):1651-1658. PubMed ID: 33147624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea.
    Mizutani H; Yoshida T; Nouchi N; Hamanaka H; Shimizu M
    J Dermatol; 1999 Jan; 26(1):11-7. PubMed ID: 10063206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Scleroderma in childhood].
    Becerril-Sánchez JF; Roldán-Labrada ME
    Bol Med Hosp Infant Mex; 1984 Oct; 41(10):556-60. PubMed ID: 6508897
    [No Abstract]   [Full Text] [Related]  

  • 47. Localized scleroderma and systemic sclerosis: is there a connection?
    Gupta RA; Fiorentino D
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on the Systemic Treatment of Pediatric Localized Scleroderma.
    Foeldvari I
    Paediatr Drugs; 2019 Dec; 21(6):461-467. PubMed ID: 31667717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis.
    Abraham D; Lescoat A; Stratton R
    Mol Aspects Med; 2024 Apr; 96():101252. PubMed ID: 38325132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case of juvenile localized scleroderma with joint sclerosis and Sjögren's syndrome in a child with precocious puberty.
    Kim HS; Choi YJ; Park YM; Kim HO; Lee JY
    J Dermatol; 2011 Oct; 38(10):1024-7. PubMed ID: 21658114
    [No Abstract]   [Full Text] [Related]  

  • 51. Presence of eosinophilia in progressive systemic sclerosis and localized scleroderma.
    Giordano M; Ara M; Valentini G; Chianese U; Bencivenga T
    Arch Dermatol Res; 1981; 271(4):411-7. PubMed ID: 7332350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on the solubility of skin collagen in scleroderma and the effect of D-penicillamine].
    Zimmermann BK; Balda BR
    Arch Dermatol Forsch; 1972; 243(4):357-63. PubMed ID: 5079382
    [No Abstract]   [Full Text] [Related]  

  • 53. Scleroderma and scleroderma-like disorders.
    Rocco VK; Hurd ER
    Semin Arthritis Rheum; 1986 Aug; 16(1):22-69. PubMed ID: 3529398
    [No Abstract]   [Full Text] [Related]  

  • 54. Pediatric scleroderma: systemic or localized forms.
    Torok KS
    Pediatr Clin North Am; 2012 Apr; 59(2):381-405. PubMed ID: 22560576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
    Lin AT; Clements PJ; Furst DE
    Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Madecassol treatment of systemic and localized scleroderma].
    Guseva NG; Starovoĭtova MN; Mach ES
    Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular microfibrils are increased in localized and systemic scleroderma skin.
    Fleischmajer R; Jacobs L; Schwartz E; Sakai LY
    Lab Invest; 1991 Jun; 64(6):791-8. PubMed ID: 2046331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scleroderma in children: an update.
    Zulian F; Cuffaro G; Sperotto F
    Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localized severe scleroderma: a retrospective study of 26 pediatric patients.
    Beltramelli M; Vercellesi P; Frasin A; Gelmetti C; Corona F
    Pediatr Dermatol; 2010; 27(5):476-80. PubMed ID: 20796242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.